Chapter
Histological Subtype: A Prognostic Factor in NSCLC
Squamous Cell Carcinoma Histological Subtypes Associated with Poor Prognosis
Adenocarcinoma Histological Subtypes Associated with Poor Prognosis
Bronchioloalveolar Cell Carcinoma Growth Pattern: A Favorable Prognostic Factor
Prognostic Implication of Molecular Markers
FDG-PET/CT in Lung Cancer: An Update
Non-Small Cell Lung Cancer
Staging of Lung Cancer – Distant Metastases
Prediction and Monitoring Response to Therapy
Whole-Body Magnetic Resonance Imaging for Staging of Lung Cancer
Technical Aspects of Whole-Body MRI
Staging of Lung Cancer Using Whole-Body MRI
Bronchoscopy/Endobronchial Ultrasound
New Developments in Videomediastinoscopy: Video-Assisted Mediastinoscopic Lymphadenectomy and Mediastinoscopic Ultrasound
Implications for Clinical Practice and Further Research
Resection in Stage I/II Non-Small Cell Lung Cancer
Surgery in Stages I and II
Role of Mediastinal Lymph Node Dissection in Non-Small Cell Lung Cancer
Surgical Technique of Systematic Lymph Node Dissection
Role of Nodal Involvement on Survival
Impact of Mediastinal Lymph Node Dissection on Operative Morbidity, Mortality and Quality of Life
Diagnostic Role of Mediastinal Lymph Node Dissection
Therapeutic Role of Mediastinal Lymph Node Dissection
Radiation Therapy for Early Stage (I/II) Non-Small Cell Lung Cancer
Radiation Therapy alone in Early Non-Small Cell Lung Cancer
Avenues for an Improvement of RT Alone in Early NSCLC
Stereotactic Body Radiation Therapy for Early Non-Small Cell Lung Cancer
Definitions of Stereotactic Body Radiation Therapy
Staging Procedures before SBRT
Implementation of Techniques in Clinical Routine
Biological Basis of Hypofractionated SBRT
Historical Aspects and Early Clinical Experience in SBRT of Lung Cancer
Follow-Up Recommendations
Extended Surgical Resection in Stage III Non-Small Cell Lung Cancer
Discussion of Stage-Related Treatment
Stage III: Definitive Chemoradiotherapy
Optimization of Combined Radiotherapy and Chemotherapy
Which Chemotherapy and Radiotherapy Regimens Are Optimal for Concurrent Chemoradiotherapy?
How Do Comorbidities Influence the Performance of Concurrent Chemoradiotherapy?
Adjuvant Therapy in Early-Stage Non-Small Cell Lung Cancer
Landmark Studies Concerning Adjuvant Platinum-Based Chemotherapy
The LACE (Lung Adjuvant Cisplatin Evaluation) Meta-Analysis (table 2)
Adjuvant Chemotherapy and Stage (table 3)
Which Chemotherapy Combination?
Patient Selection and Predictive or Prognostic Factors
Postoperative Irradiation in Non-Small Cell Lung Cancer
Altered Fractionation Schemes in Radiotherapy
Hypofractionated Stereotactic Body Radiotherapy for NSCLC (Stage I)
Hyperfractionated Accelerated Radiotherapy for Stage III NSCLC
Chemotherapy of Advanced Non-Small Cell Lung Cancer
Cisplatin- vs. Carboplatin-Based Chemotherapy
Elderly Patients and Patients with Reduced Performance Status
Systemic Chemotherapy in Patients Progressing after First-Line Chemotherapy
Clinical Manifestations of Advanced Lung Carcinoma
Palliative Potential of Radiotherapy
Treatment of Limited Disease Small Cell Lung Cancer
Radiochemotherapy in Extensive Disease Small Cell Lung Cancer ED-SCLC
Radiotherapy for Extensive Stage Small Cell Lung Cancer
Prophylactic Cranial Irradiation
Controversies in the Treatment of Advanced Stages of Small Cell Lung Cancer
Prophylactic Cranial Irradiation after First-Line Chemotherapy
Complementary and Alternative Medicinein Lung Cancer Patients: A Neglected Phenomenon?
Controversies in the Treatment of Lung Cancer
( Frontiers of Radiation Therapy and Oncology )
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
